Data as of Nov 28
| +0.23 / +0.70%|
The 20 analysts offering 12-month price forecasts for Merck KGaA have a median target of 97.99, with a high estimate of 118.56 and a low estimate of 67.36. The median estimate represents a +195.32% increase from the last price of 33.18.
The current consensus among 21 polled investment analysts is to Hold stock in Merck KGaA. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.